We also observed a significant increase in the levels of TGF-β (Fig. 2B) in the plasma samples from T2DM volunteers compared to healthy individuals indicating a possible underlying mechanism that is responsible for decreasing the expression of GCLC in individuals with T2DM. The gene discussed is GCLC; the disease is type 2 diabetes mellitus.